Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) CEO James Lanthier and Chief Scientific Officer Joseph Araujo joined Proactive to discuss the significance of synthesizing additional promising candidates from its Family 3 of next-generation drug candidates.
The duo say the group will initiate proof of concept preclinical studies to further measure the viability of these compounds as daily pro-cognitive take-home medication.